Skip to content
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filing
Company
Our Team
Governance
ESG
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filing
Company
Our Team
Governance
ESG
Search
NYSE American: IGC
Investor Relations
Committed to transparency and the advancement of next-generation therapies for neurodegenerative diseases through rigorous science and AI-driven innovation.
All Years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
IGC PHARMA to Present at the Planet MicroCap Showcase VEGAS 2023
April 18, 2023
Read More →
Investor Summit March 2023
March 24, 2023
Read More →
IGC Announces Rebranding Changes Name to IGC Pharma Inc
March 20, 2023
Read More →
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022
February 14, 2023
Read More →
IGC to be Featured in Feb. 10 Radius Research Investor Webinar
February 8, 2023
Read More →